Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study.

Min ZhangGuangdi LiJia ShangChen PanMinxiang ZhangZhibiao YinQing XieYanzhong PengQing MaoXinqiang XiaoYongfang JiangKaizhong LuoYun XuHai DingWenzhou FanVidaurre DiegoMahmoud Reza PourkarimErik De ClercqGuiqiang WangGuo-Zhong Gong

Published in: Hepatology international (2020)

HBV RNA at week 12 is an effective monitor of HBeAg seroconversion in HBeAg-positive patients treated with pegylated interferons.

Keyphrases

hepatitis b virus
liver failure
end stage renal disease
ejection fraction
newly diagnosed
patient reported